Category: Vaccine Headlines
How to Help Patients Navigate a Newly Complex Vaccine Season
MedPageToday In years past, once the calendar moved into September, there were straightforward recommendations across healthcare settings being provided to all adult patients about the benefits of receiving the annual influenza vaccine. Healthcare providers and patients are no longer in such a simple landscape for fall 2023. Along with the already-available influenza vaccines, two recently […]
Sep 12, 2023
Your fall guide to COVID, RSV and flu vaccines
PBS NewsHour As temperatures cool, the risks of respiratory illness rise. This year, there are more vaccine options to consider that are designed to prevent serious illness from flu, COVID and RSV. “All three are, in general, strongly recommended for the populations they’re intended for,” said Dr. Payal Patel, an infectious disease physician at Intermountain […]
Sep 5, 2023
Majority of US dog owners now skeptical of vaccines, including for rabies: study
The Hill A new study found that dog owners in the U.S. are growing more skeptical of vaccinating their four-legged friends — including to help prevent rabies. The study, published Saturday in the medical journal Vaccine, found that 53 percent of dog owners had some concern about the safety, efficacy or necessity of canine vaccines. Additionally, […]
Aug 29, 2023
Who Should Get a COVID Booster This Fall?
MedPageToday While the FDA and CDC have yet to weigh in on fall COVID boosters, experts in infectious disease and public health are already discussing who should get them, and who may not need to. High-risk groups get a resounding “yes” — but when it comes to younger, healthy adults, the answer is less clear. There’s […]
Aug 29, 2023
FDA Approves Vaccine for Pregnant Individuals to Prevent Respiratory Syncytial Virus in Infants
MedPageToday The FDA approved Pfizer’s bivalent respiratory syncytial virus (RSV) prefusion F protein vaccine (Abrysvo) for use in pregnant individuals to protect newborns from serious RSV-related outcomes. Even though the vaccine was administered in trials starting at 24 weeks’ gestation, the agency approved giving the shot at 32 to 36 weeks’ gestation over a possible risk for […]
Aug 22, 2023
COVID boosters are still weeks away as cases surge in the U.S.
Axios As COVID-19 cases and hospitalizations creep up during a summer wave of heightened virus activity, updated vaccines are still likely weeks away. Americans have largely tuned out COVID, but the latest COVID uptick is a reminder that the virus continues to circulate and mutate — though the threat is far below pandemic-era levels. Health officials face a challenge convincing a […]
Aug 22, 2023
COVID shots in same arm may elicit better immune response
CIDRAP Sequential vaccines, like those used for COVID-19, may elicit a greater immune response if the recipient has the same arm injected, called ipsilateral vaccination, as opposed to contralateral vaccination, in which the primary vaccination is delivered in one arm and booster dose is delivered to the opposite. The research is published in EBioMedicine. German scientists tested immune response […]
Aug 15, 2023
Covid Vaccine Makers’ Stocks Crash To Multiyear Lows Monday As Sales Keep Sliding
Forbes Moderna and BioNTech shares both cratered to their lowest price in years Monday as the companies behind the most widely-circulated mRNA Covid-19 vaccines grapple with investor disappointment with crashing revenues. BioNTech and Moderna’s stocks fell 8% and 6%, respectively, a decline spurred by BioNTech’s earnings report revealing the German firm’s sales fell 95% year-over-year […]
Aug 8, 2023
UK Health Security Agency unveils world-leading Vaccine Development and Evaluation Centre
Medical News.Net The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide. The center is situated at the UKHSA’s Porton Down site, where it is co-located with other services delivered separately […]
Aug 8, 2023
Pfizer 2Q numbers tumble and COVID-19 vaccine, treatment sales dry up
Washington Post Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall Street expect a rebound in the back half of 2023. Pfizer recorded no U.S. sales of its treatment, Paxlovid, in the recently completed quarter, as the company shifts to selling the pills on the commercial market after contracting […]
Aug 1, 2023